Table 2.

Univariate analysis for the main clinical outcomes evaluated at 36 months after transplant.

Table 2.
  • OS: overall survival; RI: relapse incidence; NRM: non-relapse mortality; TRX: transplantation; CMV: cytomegalovirus.